Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fulminant Anaphylaxis.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

World Allergy Organization survey on the diagnosis and management trends of perioperative anaphylaxis.

The World Allergy Organization journal·2026
Same author

More Than Moderate-Dose Inhaled Corticosteroid Therapy for Difficult-to-Treat Asthma: One Step Too Many?

The journal of allergy and clinical immunology. In practice·2025
Same author

Where is academic medicine going?: Part 2. Academic career and patient care.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2024
Same author

Where is academic medicine going?: Part 1. Medical education and research.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2024
Same author

Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee.

The World Allergy Organization journal·2024

Related Experiment Video

Updated: May 20, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Chapter 4: Stinging insect allergy and venom immunotherapy.

Alan P Koterba, Paul A Greenberger

    Allergy and Asthma Proceedings
    |July 17, 2012
    PubMed
    Summary

    Hymenoptera venom immunotherapy effectively prevents future anaphylaxis in patients with a history of severe reactions. This treatment is recommended for those with prior anaphylaxis, not just large local reactions, offering significant protection.

    Area of Science:

    • Allergy and Immunology
    • Toxicology
    • Entomology

    Background:

    • The Hymenoptera order encompasses bees, wasps, and ants, with specific species like Africanized bees and fire ants posing significant sting risks.
    • Stings can cause local reactions or severe anaphylaxis, with risk factors including prior anaphylaxis and positive venom skin tests.

    Purpose of the Study:

    • To differentiate treatment indications for Hymenoptera sting reactions, specifically large local reactions versus anaphylaxis.
    • To evaluate the efficacy of venom immunotherapy (IT) in preventing recurrent anaphylaxis.

    Main Methods:

    • Review of clinical outcomes for patients experiencing large local reactions versus anaphylaxis after Hymenoptera stings.
    • Analysis of anaphylaxis recurrence rates in patients undergoing Hymenoptera venom immunotherapy (IT).

    More Related Videos

    Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
    09:45

    Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects

    Published on: April 21, 2018

    Extracting Venom from the Parasitoid Wasp Trichogramma dendrolimi Using an Artificial Host
    03:53

    Extracting Venom from the Parasitoid Wasp Trichogramma dendrolimi Using an Artificial Host

    Published on: October 6, 2023

    Related Experiment Videos

    Last Updated: May 20, 2026

    Basophil Activation Test for Allergy Diagnosis
    07:22

    Basophil Activation Test for Allergy Diagnosis

    Published on: May 31, 2021

    Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
    09:45

    Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects

    Published on: April 21, 2018

    Extracting Venom from the Parasitoid Wasp Trichogramma dendrolimi Using an Artificial Host
    03:53

    Extracting Venom from the Parasitoid Wasp Trichogramma dendrolimi Using an Artificial Host

    Published on: October 6, 2023

    Main Results:

    • Patients with a history of anaphylaxis and positive skin tests have a high risk (60% adults, 20-32% children) of future reactions.
    • Venom immunotherapy (IT) significantly reduces anaphylaxis incidence to 3% after 4 years, with long-term protection.

    Conclusions:

    • Hymenoptera venom immunotherapy is indicated for patients with a history of anaphylaxis, not large local reactions.
    • IT is highly effective in preventing subsequent sting-induced anaphylaxis, with sustained benefits.